Business Wire

Seoul Semiconductor Applies Violeds Disinfection Technology to Luxury Sedan Genesis G90

Share

UV-C disinfection technology solution, Violeds, developed by Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a globally recognized optical semiconductor manufacturer, is installed in the console boxes of Genesis, a global luxury vehicle brand, with the disinfection technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005088/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

[Photo 1] Violeds UV-C LEDs are applied inside of the armrest console box of Genesis G90 (Graphic: Business Wire)

Luxury sedan Genesis G90 was officially launched for the market in the first half of 2022. The armrest console box in the back of G90 is equipped with UV-C LED lamps to disinfect passengers’ belongings in preparation for the era of COVID-19. Seoul Semiconductor’s violeds technology is applied to these UV-C LED lamps. Depending on its models, 6 to 12 LED lamps are installed, eliminating up to 99.9% of harmful germs (E.coli, staphylococcus aureus, and pneumobacilli) in personal possessions within 10 minutes after the lid is closed.

* The test results offered by Hyundai Motor Company and validated by Intertek, a global testing and certification agency, are subject to change depending on real environments

Violeds is a patented solution developed and massively applied for the first time in the world by Seoul Viosys, Seoul Semiconductor’s subsidiary. It prevents the growth of germs and bacteria with UV LEDs. According to 2021 data from Omdia, a market research agency, Seoul Viosys ranks 1st in the world in UV LED technology.

Seoul Viosys has successfully developed air sterilization solutions, as well as violeds-based surface disinfection systems. In August 2021, the company held a press conference to release its solution to prevent the spread of the delta variant, which is able to remove 99% of indoor airborne viruses. Based on the test results, it demonstrated the process of disinfecting auto air conditioning systems at CES 2022, making its technological prowess be globally recognized.

“We are very pleased to supply violeds-based UVC LEDs to global luxury brand Genesis G90. Operating our own auto air and surface sterilization lab, we have done our utmost to further develop UV LED disinfection technology. As a result, violeds technology will take the lead in expanding vehicle indoor healthcare markets in the world,” said a Seoul Semiconductor official.

He added, “acquiring the AEC-Q102 certification, the automotive LED reliability standard, violeds technology will become an optimized solution for auto healthcare projects required by clients.”

Based on more than 30 years of R&D experiences in optical semiconductor, Seoul Semiconductor has successfully established a product portfolio with all wavelength bands (200 ~ 1,600nm) from UV to visible rays and IR (VCSEL) applicable to auto solutions, holding 18,000 tech patents and thereby maintaining technological superiority in global markets.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Seoul Semiconductor Co., Ltd.
Jinseop Jung
Tel: +82-70-4391-8555
Email: jjs8732@seoulsemicon.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mundipharma acquires all assets and rights related to REZZAYO ® (rezafungin) , reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area24.4.2024 22:01:00 CEST | Press release

Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafunginis a novel once-weekly echinocandin indicated for the treatment of invasive candidiasis in adults.1 Invasive candidiasis, is a severe, life-threatening infection of the bloodstream and/or deep/visceral tissues.2,3 It affects seriously ill people, especially those with a weakened immune systemand the mortality rate can be 40%4 or more.5,6 It can place a large burden on the healthcare system, with the potential for extended treatment regimens and long hospital stays.6 Over the last 15 years, there have been no new treatments and morbidity and mortality rates remain largely the same, indicating the need for alternative treatment options.7,8 “This acquisition places Mundipharma in the best position to realise the full potential of rezafungin inclu

Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting24.4.2024 22:01:00 CEST | Press release

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024. “Our presentations at this year’s ASCO highlight the strength of our growing oncology portfolio and our commitment to developing treatments that address the unmet needs of patients with B-cell malignancies and solid tumors,” Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “The exciting data we will share during ASCO showcase BRUKINSA’s uniquely differentiated clinical profile and add to the growing body of evidence supporting its role across the blood cancer treatment paradigm.” BeiGene will share new data for BRUKINSA (zanubrutinib), which add to the robust efficacy and safety evidence differentiating it within the BTK class. Key highlights include: A network meta-analysis co

TSMC Celebrates 30 th North America Technology Symposium with Innovations Powering AI with Silicon Leadership24.4.2024 21:30:00 CEST | Press release

TSMC (TWSE: 2330, NYSE: TSM) today unveiled its newest semiconductor process, advanced packaging, and 3D IC technologies for powering the next generation of AI innovations with silicon leadership at the Company’s 2024 North America Technology Symposium. TSMC debuted the TSMC A16TM technology, featuring leading nanosheet transistors with innovative backside power rail solution for production in 2026, bringing greatly improved logic density and performance. TSMC also introduced its System-on-Wafer (TSMC-SoW™) technology, an innovative solution to bring revolutionary performance to the wafer level in addressing the future AI requirements for hyperscaler datacenters. This year marks the 30th anniversary of TSMC’s North America Technology Symposium, and more than 2,000 attended the event, growing from less than 100 attendees 30 years ago. The North America Technology Symposium in Santa Clara, California kicks off TSMC Technology Symposiums around the world in the coming months. The symposiu

Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer24.4.2024 18:50:00 CEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products, and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced the appointment of Steve Hershkowitz as its new Chief Revenue Officer (CRO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424061249/en/ Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer (Photo: Business Wire) “Steve’s leadership and extensive experience scaling businesses to deliver top-line growth will expand our sales reach to capture new logos and increase our opportunity to provide even greater value to our clients,” said Rimini Street president and CEO Seth Ravin. “The global revenue team and I are excited to work closely together with Steve to drive growth and broader capabilities for our company.” Leading the Next Chapter of Sales Growth and Continued Success f

Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System24.4.2024 18:00:00 CEST | Press release

From April 16th to 17th, the BloombergNEF (BNEF) Summit was held in New York, USA. The BNEF Summit brings together energy, finance, and technology professionals to facilitate the exchange of ideas, insights, and connections. This was Hithium's first time attending after its global launch in 2023. Hithium was also invited to host a roundtable discussion on the topic of "Next Generation Battery Energy Storage System: Latest Technology Trends and Impact on Project Economics," led by Hithium Director of Global Applications Engineering, Neil Bradshaw. The discussion focused on the future development trends of energy storage and included insights on Hithium's technology innovations, global application practices, and international development for global energy green transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423336349/en/ BNEF summit roundtable hosted by HiTHIUM (Photo: Business Wire) Hithium’s advantages on

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye